LMR Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

LMR Partners’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,000	Closed	-$282K	–	1024
2022 Q4	$282K	Hold	10,000	–	–	﹤0.01%	959
2022 Q3	$329K	Buy	+10,000	New	+$367K	0.01%	949

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LMR Partners's ARKG Position: Q1 2023 in Review

LMR Partners sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 10,000 shares — an estimated $282K sold.

LMR Partners first reported a position in ARKG in Q3 2022 and held it in 2 quarters. The position peaked at $329K in Q3 2022. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

LMR Partners reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
LMR Partners sold 10,000 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $282K.
LMR Partners first reported a position in ARK Genomic Revolution ETF in Q3 2022 and held it in 2 quarters.
LMR Partners's ARK Genomic Revolution ETF position peaked at $329K in Q3 2022.
295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on LMR Partners's 13F filing for Q1 2023, filed 15 May 2023.